Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX)
Observational, Prospective, Cohort Study of Mpox Infection in Brazil - NETPOX Cohort
Hospital Israelita Albert Einstein
80 participants
Jul 16, 2024
OBSERVATIONAL
Conditions
Summary
The study is a prospective cohort that evaluates the clinical and immune-metabolic variables that may be linked to the risk and severity of the infection or even hospitalization or death in patients infected with the Mpox virus in Brazil. The expectation is to include at least 80 patients over six months, with a follow-up of 90 days from inclusion, through contact via decentralized visits.
Eligibility
Inclusion Criteria2
- Men and women aged ≥ 18 years with confirmed MPOX infection.
- (laboratory-confirmed monkeypox infection is defined as determined by PCR, culture, or antigen test obtained from a sample collected from blood, oropharynx, anal or skin lesion within 4 days of randomization)
Exclusion Criteria2
- Inability to provide informed consent;
- Patient who, judging by the study team, does not have a condition for decentralized follow-up
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Evaluation of mpox viral genomic
Evaluation of metabolomics of the total plasma, oropharynx, and skin samples.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05784038